Pencegahan Kanker Penelitian Sintilimab dan Kemoradioterapi: Meningkatkan Respons pada Kanker Esofagus
Pencegahan Kanker Penelitian Marcus Johnson ASIA, CANCER PREVENTION, CHINA, CLINICAL TRIALS, COVID-19, DEPARTMENT OF THORACIC SURGERY, ES, HPV VACCINE, INSTITUTE, LENG, MEDICINE, MEXICO, NORTH AMERICA, OF MEDICINE, RESEARCH, SCHOOL OF MEDICINE, SICHUAN CANCER CENTER, SICHUAN CANCER HOSPITAL, UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA, XU Sintilimab Meningkatkan Tingkat Respon pada Kanker Esofagus Resektabel
